VACCINES. According to a recent study entitled “The Safety of Covid19 Vaccinations — We Should Rethink the Policy”, published in the academic journal “Vaccines”, we must accept 4 deaths and 16 serious side effects per 100,000 vaccinations to save the lives of 2 to 11 people.
NewsVoice reporter Jesper Johansson asked the responsible healthcare authority The Public Health Agency of Sweden in Sweden about their opinion but they dodged the questions saying they have no information about the study.
The study was later withdrawn. We do not currently know whether the study was withdrawn due to any threat of retaliation or whether the withdrawal depends on whether the study has shortcomings.
The Safety of Covid19 Vaccinations — We Should Rethink the Policy
“Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death.
We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to extract the number of cases reporting severe side effects and the number of cases with fatal side effects.
Result: The NNTV is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate. The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination.
Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy.”
Video report by Jesper Johansson | Text: NewsVoice
- MDPI: The Safety of COVID-19 Vaccinations—We Should Rethink the Policy (PDF via NewsVoice)
- Poznan University of the Medical Sciences, Pediatric Hospital, Polen